Home > Boards > US OTC > Miscellaneous >

Axim Biotechnologies Inc. (AXIM)

Add AXIM Price Alert      Hide Sticky   Hide Intro
Moderator: TUXI, Blue Skys
Search This Board: 
Last Post: 7/30/2021 4:47:30 PM - Followers: 102 - Board type: Free - Posts Today: 2

News updates July 23rd 2020
"The NeuCovix™ test was compared to a gold standard pseudovirus-based test. NeuCovix™ accurately classified serum from patients who strongly neutralized SARS-CoV-2 and serum from patients who poorly neutralized the virus. Additionally, NeuCovix™ did not cross-react with serum from patients with seasonal respiratory infections including seasonal coronaviruses, suggesting that the test has 100 percent specificity for COVID-19. 


July 15, 2020 08:30 ET Source: AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 15, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological research, today announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.

Unlike currently available serological COVID-19 tests that detect an antibody response to the virus, AXIM’s rapid 10-minute test measures a specific subpopulation of antibodies to block binding of the virus to host cell receptors. While there are expensive, time consuming laboratory tests that measure neutralizing antibodies, NeuCovixTM differs in that it is a portable, low cost, rapid point-of-care test with results in 10 minutes.

“We are hopeful our test fills an important need in these uncertain times. While other tests merely show whether someone was infected with coronavirus, we took it a step further by creating a test that stratifies individuals into those who have neutralizing antibodies, which are essential in preventing reinfection, and those who don’t. The test can be deployed for point of care use in convalescent plasma transfusions to severely ill patients and for evaluating efficacy of upcoming vaccines in generating protective antibodies,” said Sergei Svarovsky, PhD, MBA, AXIM’s CSO and co-inventor of NeuCovixTM.

An immediate application of NeuCovixTM, a point-of-care test, is to measure levels of neutralizing antibodies in convalescent plasma so that plasma with the highest levels of neutralizing antibodies can be identified and administered to patients fighting COVID-19.  Without this knowledge, many patients could be undertreated with non-neutralizing plasma and may not benefit from this treatment. 

Another application of NeuCovixTM is to help ensure that vaccines elicit high levels of neutralizing antibodies. When a vaccine is available, manufacturers can employ the NeuCovixTM rapid, point-of-care test to evaluate protective immune responses in vaccine recipients.

AXIM® Biotech CEO John W. Huemoeller II commented, Our goal was to make this test, accurate, fast and relatively inexpensive so it could serve as an ‘Immunity Passport port™’ for vaccine developers around the world as they begin larger Phase II and III clinical trials. We are optimistic that NeuCovixTM will be widely used, becoming the gold standard in assessing levels of immunity.

Doug Lake, Ph.D. and co-inventor of NeuCovixTM commented, “Everybody who recovers from COVID-19 makes antibodies against the virus, but since all antibodies are not created equal, you really want to know if the antibodies you make neutralize the virus. People who recover want to make sure they are protected from re-infection and that they won’t infect others.”

AXIM also announced the filing of a pre-Emergency Use Authorization Application (EUA) and has already initiated dialogue with the FDA in order to finalize its EUA submission. The intellectual property relating to the novel serological test is the subject of Provisional Patent Application No. 63/023,646 “Convalescent Plasma Testing and Treatment” filed on May 12, 2020. 

About AXIM® Biotechnologies
Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated oncology company developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The Company is also developing novel antibodies for therapeutic and diagnostic uses for oncological therapeutics. For more information, please visit www.AXIMBiotech.com.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#1538  Sticky Note AXIM(R) Biotechnologies Manufacturing Partner Empowered Diagnostics Files Emerge Dean14 03/24/21 09:06:58 AM
#1790   https://www.koreabiomed.com/news/articleView.html?idxno=11795 Dean14 07/30/21 04:47:30 PM
#1789   Yes, That's the developing cup and handle that Blue Skys 07/30/21 02:09:47 PM
#1788   No proof on my part, but I think TexasMarvL 07/29/21 11:44:55 PM
#1787   Linked from AXIM Website SEC filings dated 06-09-2021. TexasMarvL 07/29/21 11:31:58 PM
#1786   So since I'm here fishing for information, you The Lieutenant 07/29/21 07:09:55 PM
#1785   This should get very exciting as soon as Blue Skys 07/29/21 05:03:34 PM
#1784   Barry Abraham, Empowered Diagnostics Dean14 07/29/21 02:21:06 PM
#1783   I've been following this stock for some time The Lieutenant 07/29/21 09:42:46 AM
#1782   The EUA feels very close now. I'm Blue Skys 07/20/21 11:52:35 PM
#1781   Saw this on another board .. Thank you 24 07/19/21 11:59:41 PM
#1780   See the short interest today on AXIM? 2.13K 24 07/19/21 11:57:50 PM
#1779   That's encouraging. John articulated some good reasons Blue Skys 07/13/21 05:13:08 PM
#1778   This just popped up on my Facebook https://www.10news.com/news/coronavirus/san- 24 07/13/21 05:00:22 PM
#1777   Chart looking verry bullish again! Let's do this!! jjr04001 07/13/21 10:05:35 AM
#1776   Nice trading today. Day 29 after the Blue Skys 07/08/21 01:51:57 PM
#1775   All good points. Thanks for the measured TexasMarvL 07/07/21 11:36:26 AM
#1774   The second quarter Ended on June 30 and Blue Skys 07/06/21 04:01:09 PM
#1773   You don't think we will hear anything from 24 07/06/21 03:40:29 PM
#1772   He added that the antibody efficient at preventing Dean14 07/01/21 09:57:45 AM
#1771   The news seems like it will probably come Blue Skys 06/29/21 05:49:28 PM
#1770   Code 1 is running us on a banner Blue Skys 06/29/21 03:16:44 AM
#1769   Delta variant could pose a big problem: nilremerlin 06/28/21 02:07:17 PM
#1768   GREAT volume janeyH 06/25/21 02:36:54 PM
#1767   Nice accumulation happening today. Blue Skys 06/25/21 02:15:24 PM
#1766   Weekly H-A price is at .80 cents. The trickybiz 06/25/21 10:15:26 AM
#1765   Paid promo in today's daily email from Stocktwits. Blue Skys 06/23/21 05:31:41 AM
#1764   I think that good things are happening with Blue Skys 06/21/21 04:05:09 PM
#1763   Had to buy more @ .7575 Dean14 06/21/21 11:27:35 AM
#1762   Blue Skys really appreciate your posts on the sctt 06/20/21 05:25:45 PM
#1761   Axim Biotechnologies Inc (OTCMKTS: AXIM) has on the Dean14 06/20/21 12:54:48 PM
#1758   We have reached (and closed above) that breakpoint trickybiz 06/18/21 09:23:49 PM
#1757   Load the boat!!! jjr04001 06/18/21 03:52:21 PM
#1756   So I don't know if you sold the edro 06/14/21 10:44:18 AM
#1755   HHahhahahhahah i know!!!! The other 2 were BNGO JP1090 06/14/21 10:11:47 AM
#1754   Let me know when you are ready to edro 06/14/21 08:25:43 AM
#1753   24...I think that update at Code 1 Supply TUXI 06/13/21 04:23:22 PM
#1752   Looking forward to a very large market. TUXI 06/13/21 04:02:29 PM
#1751   I believe it's because they're selling the test 24 06/13/21 12:44:49 PM
#1750   so, really, what did happen on friday? why janeyH 06/13/21 12:33:09 PM
#1749   I've followed you for some time here and Blue Skys 06/12/21 10:24:27 PM
#1748   To clarify...The antibody does not protect you from TUXI 06/12/21 05:01:24 AM
#1747   Axim's ImmunoPass, distributed by Empowered Diagnostics, is the TUXI 06/12/21 04:53:45 AM
#1746   The difference this time is we started from 24 06/12/21 12:25:35 AM
#1745   You're truly the dd expert on here. jjr04001 06/12/21 12:23:33 AM
#1744   No kidding jjr! Blue Skys 06/12/21 12:05:12 AM
#1743   Still not too late to get back in. jjr04001 06/11/21 11:45:26 PM
#1742   Dang, this is the 3rd time that’s happened JP1090 06/11/21 09:44:28 PM
#1741   Looks like it took 2 days of time Blue Skys 06/11/21 09:05:26 PM
#1740   Wow, talk about a $900,000. purchase breakout, of trickybiz 06/11/21 08:26:48 PM
#1739   Yes it has. I think that it Blue Skys 06/11/21 06:06:37 PM
Consent Preferences